|
|
|
Insider
Information: |
Kong Garheng |
Relationship: |
Director, 10% Owner |
City: |
Chapel Hill |
State: |
NC |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
1,448,305 |
|
Indirect Shares
|
6,795,621 |
|
|
Direct
Value |
$2,505,911 |
|
|
Indirect Value
|
$1,529,015 |
|
|
Total
Shares |
8,243,926 |
|
|
Total
Value |
$4,034,926 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
15.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Laboratory Corp of America |
LH |
Director |
2024-02-07 |
11,898 |
2014-12-02 |
0 |
Premium* |
|
Melinta Therapeutics, Inc |
MLNT |
Director |
2015-10-26 |
2,830 |
2015-10-26 |
0 |
Premium* |
|
Strongbridge Biopharma Plc |
SBBP |
Director |
2021-10-05 |
0 |
2019-05-15 |
0 |
Premium* |
|
Castle Biosciences Inc |
CSTL |
See Remarks |
2020-05-12 |
1,433,577 |
2019-07-29 |
0 |
Premium* |
|
Venus Concept Inc |
VERO |
Director, 10% Owner |
2019-11-07 |
0 |
2021-12-15 |
6,795,621 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
33 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LH |
Laboratory Corp of Americ... |
Director |
|
2014-12-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
624 |
624 |
0 |
- |
|
LH |
Laboratory Corp of Americ... |
Director |
|
2015-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,503 |
2,127 |
0 |
- |
|
LH |
Laboratory Corp of Americ... |
Director |
|
2016-03-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,237 |
3,364 |
0 |
- |
|
LH |
Laboratory Corp of Americ... |
Director |
|
2017-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,560 |
4,924 |
0 |
- |
|
LH |
Laboratory Corp of Americ... |
Director |
|
2018-02-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,263 |
6,187 |
0 |
- |
|
LH |
Laboratory Corp of Americ... |
Director |
|
2019-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,038 |
7,225 |
0 |
- |
|
SBBP |
Strongbridge Biopharma Pl... |
Director |
|
2019-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
40,000 |
0 |
- |
|
LH |
Laboratory Corp of Americ... |
Director |
|
2020-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,227 |
8,452 |
0 |
- |
|
SBBP |
Strongbridge Biopharma Pl... |
Director |
|
2020-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
80,000 |
0 |
- |
|
VERO |
Venus Concept Inc |
Director |
|
2020-06-16 |
4 |
A |
$0.00 |
$0 |
I/I |
1,200,000 |
5,195,621 |
0 |
- |
|
LH |
Laboratory Corp of Americ... |
Director |
|
2021-02-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
986 |
9,438 |
0 |
- |
|
SBBP |
Strongbridge Biopharma Pl... |
Director |
|
2021-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
81,756 |
0 |
- |
|
SBBP |
Strongbridge Biopharma Pl... |
Director |
|
2021-10-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(63,993) |
0 |
0 |
- |
|
LH |
Laboratory Corp of Americ... |
Director |
|
2022-02-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
771 |
10,209 |
0 |
- |
|
LH |
Laboratory Corp of Americ... |
Director |
|
2023-02-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
742 |
10,951 |
0 |
- |
|
LH |
Laboratory Corp of Americ... |
Director |
|
2024-02-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
947 |
11,898 |
0 |
- |
|
CSTL |
Castle Biosciences Inc |
10% Owner |
|
2019-07-29 |
4 |
S |
$16.00 |
$144 |
D/D |
(9) |
1,771,077 |
0 |
- |
|
CSTL |
Castle Biosciences Inc |
10% Owner |
|
2019-07-29 |
4 |
OE |
$0.02 |
$231 |
D/D |
11,572 |
1,771,086 |
0 |
- |
|
SBBP |
Strongbridge Biopharma Pl... |
Director |
|
2021-10-01 |
4 |
D |
$2.06 |
$36,592 |
D/D |
(17,763) |
63,993 |
0 |
- |
|
SBBP |
Strongbridge Biopharma Pl... |
Director |
|
2021-05-14 |
4 |
D |
$2.35 |
$45,120 |
D/D |
(19,200) |
41,756 |
0 |
- |
|
MLNT |
Melinta Therapeutics, Inc |
Director |
|
2015-10-26 |
4 |
B |
$17.43 |
$49,335 |
D/D |
2,830 |
2,830 |
2.39 |
- |
|
SBBP |
Strongbridge Biopharma Pl... |
Director |
|
2020-05-15 |
4 |
D |
$2.86 |
$54,466 |
D/D |
(19,044) |
60,956 |
0 |
- |
|
CSTL |
Castle Biosciences Inc |
10% Owner |
|
2020-01-31 |
4 |
AS |
$30.02 |
$750,388 |
D/D |
(25,000) |
1,783,577 |
0 |
- |
|
CSTL |
Castle Biosciences Inc |
10% Owner |
|
2020-01-28 |
4 |
AS |
$30.02 |
$750,493 |
D/D |
(25,000) |
1,808,577 |
0 |
- |
|
CSTL |
Castle Biosciences Inc |
10% Owner |
|
2020-02-06 |
4 |
AS |
$31.03 |
$775,750 |
D/D |
(25,000) |
1,733,577 |
0 |
- |
|
33 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|